InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,307.88
(
0.48%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.73
(
0.36%
)
Bitcoin
61,479.27
(
-0.21%
)

Replies to post #189909 on Elite Pharmaceuticals Inc (ELTP)

Replies to #189909 on Elite Pharmaceuticals Inc (ELTP)

Je3232

03/19/16 5:59 PM

#189914 RE: dr_lowenstein #189909

Lol. Sorry to say you are wrong. FDA gave this a priority review. Good luck

lasers

03/19/16 7:33 PM

#189925 RE: dr_lowenstein #189909

b]SequestOx ..has been accepted and granted priority review by the United States Food and Drug Administration ("FDA"). The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016.




NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM (ELI-200), Elite's lead opioid abuse-deterrent candidate for the management of moderate to severe pain where the use of an opioid analgesic is appropriate, has been accepted and granted priority review by the United States Food and Drug Administration ("FDA"). The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016.